AVNT vs PATH · P/E 32, rev $3.24B vs P/E 19, rev $1.61B
Avient Corp (AVNT) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Avient Corp (AVNT) is a specialty chemicals company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AVNT revenue for 2024-12-31 was $3.24B. Net income was $170.7M. Revenue was up 3.1% from 2023-12-31 to 2024-12-31. AVNT currently screens at market cap $3.13B and trailing P/E 31.7.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AVNT currently screens at market cap $3.13B and trailing P/E 31.7. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AVNT and PATH stock pages for the full models.
Not investment advice.